Thomas R. DIRAIMONDO

Person

La Jolla, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods related to tumor activated antibodies targ...
- Patent number 11,555,078
- Issue date Jan 17, 2023
- JANUX THERAPEUTICS, INC.
- David Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Transglutaminase 2 (TG2) inhibitors
- Patent number 11,548,892
- Issue date Jan 10, 2023
- Sitari Pharma, Inc.
- David Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cleavable linker compositions and methods
- Patent number 11,512,113
- Issue date Nov 29, 2022
- JANUX THERAPEUTICS, INC.
- David Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS
- Publication number 20240376226
- Publication date Nov 14, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING EGFR AND CD3 AND USES THEREOF
- Publication number 20240254241
- Publication date Aug 1, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20240252669
- Publication date Aug 1, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING TROP2 AND CD3 AND USES THEREOF
- Publication number 20240092931
- Publication date Mar 21, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20240059790
- Publication date Feb 22, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDE COMPOSITIONS AND METHODS FOR ANTI-CD3 BINDING DOMAINS
- Publication number 20240043536
- Publication date Feb 8, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING PSMA AND CD3 AND USES THEREOF
- Publication number 20240043565
- Publication date Feb 8, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HALF-LIFE EXTENDING COMPOSITIONS AND METHODS
- Publication number 20240034814
- Publication date Feb 1, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20240034806
- Publication date Feb 1, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-L1 AND METHODS O...
- Publication number 20230406937
- Publication date Dec 21, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING HER2 AND CD3 AND USES THEREOF
- Publication number 20230406955
- Publication date Dec 21, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES TARGETING TROP2 AND USES THEREOF
- Publication number 20230357429
- Publication date Nov 9, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR ACTIVATED MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-...
- Publication number 20230357447
- Publication date Nov 9, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20230348618
- Publication date Nov 2, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS
- Publication number 20230220109
- Publication date Jul 13, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR ACTIVATED T CELL ENGAGERS AND METHODS OF USE THEREOF
- Publication number 20230220105
- Publication date Jul 13, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLEAVABLE LINKER COMPOSITIONS AND METHODS
- Publication number 20230147782
- Publication date May 11, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20220177600
- Publication date Jun 9, 2022
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CLEAVABLE LINKER COMPOSITIONS AND METHODS
- Publication number 20220048949
- Publication date Feb 17, 2022
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORY T CELL RECEPTOR PEPTIDES AND DISCOVERY METHODS
- Publication number 20210371849
- Publication date Dec 2, 2021
- Janux Therapeutics, Inc.
- David CAMPBELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED T CELL RECEPTORS
- Publication number 20210115106
- Publication date Apr 22, 2021
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED BISPECIFIC T CELL RECEPTORS
- Publication number 20200385440
- Publication date Dec 10, 2020
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas R. DIRAIMONDO

Person

Patents Grantslast 30 patents

Compositions and methods related to tumor activated antibodies targ...

Transglutaminase 2 (TG2) inhibitors

Cleavable linker compositions and methods

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS

ANTIBODIES TARGETING EGFR AND CD3 AND USES THEREOF

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

ANTIBODIES TARGETING TROP2 AND CD3 AND USES THEREOF

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

PEPTIDE COMPOSITIONS AND METHODS FOR ANTI-CD3 BINDING DOMAINS

ANTIBODIES TARGETING PSMA AND CD3 AND USES THEREOF

HALF-LIFE EXTENDING COMPOSITIONS AND METHODS

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-L1 AND METHODS O...

ANTIBODIES TARGETING HER2 AND CD3 AND USES THEREOF

OPTIMIZED ANTIBODIES TARGETING TROP2 AND USES THEREOF

TUMOR ACTIVATED MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-...

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS

TUMOR ACTIVATED T CELL ENGAGERS AND METHODS OF USE THEREOF

CLEAVABLE LINKER COMPOSITIONS AND METHODS

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

CLEAVABLE LINKER COMPOSITIONS AND METHODS

INHIBITORY T CELL RECEPTOR PEPTIDES AND DISCOVERY METHODS

MODIFIED T CELL RECEPTORS

MODIFIED BISPECIFIC T CELL RECEPTORS